The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Solid Tumor Therapeutics Market Research Report 2025
Synopsis
In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.
The global Solid Tumor Therapeutics market was valued at US$ 118040 million in 2023 and is anticipated to reach US$ 215470 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Solid Tumor Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Therapeutics.
Report Scope
The Solid Tumor Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid Tumor Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Tumor Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hoffmann-La Roche
Johnson & Johnson
Novartis
AstraZeneca
Biogen Idec
Boehringer Ingelheim
GlaxoSmithKline
Eli Lilly
Kyowa Hakko Kirin
Abbott Laboratories
Baxter International
Segment by Type
Chemotherapy
Hormone Therapy
Immunotherapy
Targeted Therapy
Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Tumor Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.
The global Solid Tumor Therapeutics market was valued at US$ 118040 million in 2023 and is anticipated to reach US$ 215470 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Solid Tumor Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Therapeutics.
Report Scope
The Solid Tumor Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid Tumor Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Tumor Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hoffmann-La Roche
Johnson & Johnson
Novartis
AstraZeneca
Biogen Idec
Boehringer Ingelheim
GlaxoSmithKline
Eli Lilly
Kyowa Hakko Kirin
Abbott Laboratories
Baxter International
Segment by Type
Chemotherapy
Hormone Therapy
Immunotherapy
Targeted Therapy
Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Tumor Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Tumor Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Hormone Therapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Solid Tumor Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Tumor Therapeutics Market Perspective (2019-2030)
2.2 Solid Tumor Therapeutics Growth Trends by Region
2.2.1 Global Solid Tumor Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Solid Tumor Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Solid Tumor Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Solid Tumor Therapeutics Market Dynamics
2.3.1 Solid Tumor Therapeutics Industry Trends
2.3.2 Solid Tumor Therapeutics Market Drivers
2.3.3 Solid Tumor Therapeutics Market Challenges
2.3.4 Solid Tumor Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Tumor Therapeutics Players by Revenue
3.1.1 Global Top Solid Tumor Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Solid Tumor Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Solid Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid Tumor Therapeutics Revenue
3.4 Global Solid Tumor Therapeutics Market Concentration Ratio
3.4.1 Global Solid Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Therapeutics Revenue in 2023
3.5 Solid Tumor Therapeutics Key Players Head office and Area Served
3.6 Key Players Solid Tumor Therapeutics Product Solution and Service
3.7 Date of Enter into Solid Tumor Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid Tumor Therapeutics Breakdown Data by Type
4.1 Global Solid Tumor Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Solid Tumor Therapeutics Forecasted Market Size by Type (2025-2030)
5 Solid Tumor Therapeutics Breakdown Data by Application
5.1 Global Solid Tumor Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Solid Tumor Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Solid Tumor Therapeutics Market Size (2019-2030)
6.2 North America Solid Tumor Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Solid Tumor Therapeutics Market Size by Country (2019-2024)
6.4 North America Solid Tumor Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Tumor Therapeutics Market Size (2019-2030)
7.2 Europe Solid Tumor Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Solid Tumor Therapeutics Market Size by Country (2019-2024)
7.4 Europe Solid Tumor Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid Tumor Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Solid Tumor Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid Tumor Therapeutics Market Size (2019-2030)
9.2 Latin America Solid Tumor Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Solid Tumor Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Solid Tumor Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Tumor Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Solid Tumor Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hoffmann-La Roche
11.1.1 Hoffmann-La Roche Company Detail
11.1.2 Hoffmann-La Roche Business Overview
11.1.3 Hoffmann-La Roche Solid Tumor Therapeutics Introduction
11.1.4 Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.1.5 Hoffmann-La Roche Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Solid Tumor Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Solid Tumor Therapeutics Introduction
11.3.4 Novartis Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Solid Tumor Therapeutics Introduction
11.4.4 AstraZeneca Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.4.5 AstraZeneca Recent Development
11.5 Biogen Idec
11.5.1 Biogen Idec Company Detail
11.5.2 Biogen Idec Business Overview
11.5.3 Biogen Idec Solid Tumor Therapeutics Introduction
11.5.4 Biogen Idec Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.5.5 Biogen Idec Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Introduction
11.6.4 Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.6.5 Boehringer Ingelheim Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Solid Tumor Therapeutics Introduction
11.7.4 GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Solid Tumor Therapeutics Introduction
11.8.4 Eli Lilly Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.8.5 Eli Lilly Recent Development
11.9 Kyowa Hakko Kirin
11.9.1 Kyowa Hakko Kirin Company Detail
11.9.2 Kyowa Hakko Kirin Business Overview
11.9.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Introduction
11.9.4 Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.9.5 Kyowa Hakko Kirin Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Solid Tumor Therapeutics Introduction
11.10.4 Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.10.5 Abbott Laboratories Recent Development
11.11 Baxter International
11.11.1 Baxter International Company Detail
11.11.2 Baxter International Business Overview
11.11.3 Baxter International Solid Tumor Therapeutics Introduction
11.11.4 Baxter International Revenue in Solid Tumor Therapeutics Business (2019-2024)
11.11.5 Baxter International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Solid Tumor Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormone Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Solid Tumor Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Solid Tumor Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Solid Tumor Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Solid Tumor Therapeutics Market Share by Region (2019-2024)
Table 10. Global Solid Tumor Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Solid Tumor Therapeutics Market Share by Region (2025-2030)
Table 12. Solid Tumor Therapeutics Market Trends
Table 13. Solid Tumor Therapeutics Market Drivers
Table 14. Solid Tumor Therapeutics Market Challenges
Table 15. Solid Tumor Therapeutics Market Restraints
Table 16. Global Solid Tumor Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Solid Tumor Therapeutics Market Share by Players (2019-2024)
Table 18. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Therapeutics as of 2023)
Table 19. Ranking of Global Top Solid Tumor Therapeutics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Solid Tumor Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Solid Tumor Therapeutics Product Solution and Service
Table 23. Date of Enter into Solid Tumor Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Solid Tumor Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Solid Tumor Therapeutics Revenue Market Share by Type (2019-2024)
Table 27. Global Solid Tumor Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Solid Tumor Therapeutics Revenue Market Share by Type (2025-2030)
Table 29. Global Solid Tumor Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Solid Tumor Therapeutics Revenue Market Share by Application (2019-2024)
Table 31. Global Solid Tumor Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Solid Tumor Therapeutics Revenue Market Share by Application (2025-2030)
Table 33. North America Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Solid Tumor Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Solid Tumor Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Solid Tumor Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Solid Tumor Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Solid Tumor Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Solid Tumor Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Solid Tumor Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Hoffmann-La Roche Company Detail
Table 49. Hoffmann-La Roche Business Overview
Table 50. Hoffmann-La Roche Solid Tumor Therapeutics Product
Table 51. Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 52. Hoffmann-La Roche Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Solid Tumor Therapeutics Product
Table 56. Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Solid Tumor Therapeutics Product
Table 61. Novartis Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. AstraZeneca Company Detail
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Solid Tumor Therapeutics Product
Table 66. AstraZeneca Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Biogen Idec Company Detail
Table 69. Biogen Idec Business Overview
Table 70. Biogen Idec Solid Tumor Therapeutics Product
Table 71. Biogen Idec Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 72. Biogen Idec Recent Development
Table 73. Boehringer Ingelheim Company Detail
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Solid Tumor Therapeutics Product
Table 76. Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 77. Boehringer Ingelheim Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Solid Tumor Therapeutics Product
Table 81. GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Eli Lilly Company Detail
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Solid Tumor Therapeutics Product
Table 86. Eli Lilly Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 87. Eli Lilly Recent Development
Table 88. Kyowa Hakko Kirin Company Detail
Table 89. Kyowa Hakko Kirin Business Overview
Table 90. Kyowa Hakko Kirin Solid Tumor Therapeutics Product
Table 91. Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 92. Kyowa Hakko Kirin Recent Development
Table 93. Abbott Laboratories Company Detail
Table 94. Abbott Laboratories Business Overview
Table 95. Abbott Laboratories Solid Tumor Therapeutics Product
Table 96. Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 97. Abbott Laboratories Recent Development
Table 98. Baxter International Company Detail
Table 99. Baxter International Business Overview
Table 100. Baxter International Solid Tumor Therapeutics Product
Table 101. Baxter International Revenue in Solid Tumor Therapeutics Business (2019-2024) & (US$ Million)
Table 102. Baxter International Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Tumor Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Solid Tumor Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Features
Figure 4. Hormone Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Targeted Therapy Features
Figure 7. Global Solid Tumor Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Solid Tumor Therapeutics Market Share by Application: 2023 VS 2030
Figure 9. Breast Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Colorectal Cancer Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Cervical Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Solid Tumor Therapeutics Report Years Considered
Figure 16. Global Solid Tumor Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Solid Tumor Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Solid Tumor Therapeutics Market Share by Region: 2023 VS 2030
Figure 19. Global Solid Tumor Therapeutics Market Share by Players in 2023
Figure 20. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Therapeutics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Solid Tumor Therapeutics Revenue in 2023
Figure 22. North America Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Solid Tumor Therapeutics Market Share by Country (2019-2030)
Figure 24. United States Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Solid Tumor Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Solid Tumor Therapeutics Market Share by Region (2019-2030)
Figure 36. China Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Solid Tumor Therapeutics Market Share by Country (2019-2030)
Figure 44. Mexico Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Solid Tumor Therapeutics Market Share by Country (2019-2030)
Figure 48. Turkey Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Solid Tumor Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Hoffmann-La Roche Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 51. Johnson & Johnson Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 54. Biogen Idec Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 58. Kyowa Hakko Kirin Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 59. Abbott Laboratories Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 60. Baxter International Revenue Growth Rate in Solid Tumor Therapeutics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
